Skip to main content
. Author manuscript; available in PMC: 2021 Dec 29.
Published in final edited form as: Breast Cancer Res Treat. 2020 Feb 14;180(2):491–501. doi: 10.1007/s10549-020-05557-x

Fig. 2.

Fig. 2

Trend of having reported chemotherapy by Recurrence Score among female hormone receptor-positive breast cancer patients, 17 SEER registries, 2004–2015. a Patients with negative axillary lymph node by Recurrence Score original categories; b Patients with 1–3 positive axillary lymph nodes by Recurrence Score original categories; c Patients with negative axillary lymph node by TAILORx categories; d Patients with 1–3 positive axillary lymph nodes by TAILORx categories